AN1 14.3% 0.8¢ anagenics limited

Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer, page-12

  1. 3,315 Posts.
    lightbulb Created with Sketch. 965
    "They have just got OUT of the Covid antibody business. And now they watch Ellumehealth pocket 230 million dollars for going INTO the Covid antigen business".

    Ellume obviously gave the subject more thought and didn't simply act in a reactionary (or speculatory) manner. One of the two know what they are doing - whilst I suspect there is a lesson to be learnt for the other one.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.001(14.3%)
Mkt cap ! $3.691M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $1.92K 240K

Buyers (Bids)

No. Vol. Price($)
3 925902 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 10.07am 21/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.